A2Z Cust2Mate Solutions Corp. (AZ), a Canadian technology player in the software application industry, has caught the eye of investors with its innovative smart cart solutions aimed at revolutionizing the..
Agora, Inc. (NASDAQ: API) presents an intriguing opportunity for investors navigating the dynamic landscape of the technology sector. Specializing in real-time engagement platforms, Agora’s stock is currently priced at $3.8,..
Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company based in Cleveland, Ohio, is making waves in the biotechnology sector. With a market capitalization of $335.59 million, Abeona is focused..
Cytek Biosciences, Inc. (NASDAQ: CTKB), a key player in the healthcare sector, specializes in the development of cutting-edge cell analysis tools that support breakthroughs in biomedical research and clinical applications...
Neuronetics, Inc. (NASDAQ: STIM) is generating buzz among investors with its promising 67.96% potential upside, as the company continues to carve out its niche in the healthcare sector, specifically within..
Tvardi Therapeutics, Inc. (TVRD) stands at the forefront of innovative healthcare solutions with its focus on developing novel, oral, small molecule therapies targeting the STAT3 pathway. This clinical-stage biopharmaceutical company,..
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a dynamic player in the biotechnology sector, is catching the eye of investors with its promising potential upside of 95.61%. With a market capitalization of..
Candel Therapeutics, Inc. (NASDAQ: CADL), a pioneering force in the biotechnology sector, is capturing investor attention with its innovative approach to cancer treatment. This clinical-stage biopharmaceutical company, headquartered in Needham,..
Immutep Limited (NASDAQ: IMMP), a Sydney-based biotechnology company, is carving a niche in the healthcare sector with its innovative immunotherapy solutions targeting cancer and autoimmune diseases. With a current market..
Investors seeking opportunities in the biotechnology sector may find Palvella Therapeutics, Inc. (PVLA) a compelling prospect. This clinical-stage biopharmaceutical company, based in Wayne, Pennsylvania, is making waves with its innovative..
Absci Corporation (NASDAQ: ABSI), a cutting-edge player in the biotechnology sector, is capturing investor attention with its innovative approach to drug creation. As a company that marries artificial intelligence with..
Pacific Biosciences of California, Inc. (NASDAQ: PACB) stands out in the healthcare sector, particularly within the medical devices industry. Based in Menlo Park, California, the company is renowned for its..
Investors with an eye on the healthcare sector may find Nyxoah SA (NASDAQ: NYXH) a compelling addition to their portfolios, especially given its recent trading dynamics and promising analyst outlook...
Aurora Cannabis Inc. (NYSE: ACB) remains a compelling company in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $311.67 million, this..
TotalEnergies SE (TTE), a leading player in the integrated oil and gas industry, is capturing investor attention with its robust dividend yield and promising upside potential. As an energy powerhouse..
Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is generating significant buzz among investors with its promising pipeline and potential upside. Specializing in the development of novel genetic medicines,..
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) stands out in the healthcare sector as a promising player in the biotechnology industry, primarily focusing on the development of innovative therapies for women’s cancers...
Erasca, Inc. (NASDAQ: ERAS), a trailblazer in the biotechnology sector, is drawing significant attention from investors with its cutting-edge approach to precision oncology. With a market capitalization of $459.55 million,..
Cidara Therapeutics, Inc. (NASDAQ: CDTX), a San Diego-based biotechnology company, is making waves in the healthcare sector with its innovative approach to treating serious diseases, particularly in the realm of..
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is a biotechnology company focused on developing innovative therapies that address hematologic disorders and cancer. With a market capitalization of $656.15 million, Rigel is making..
